Insights into placental cell senescence in pregnancy, preeclampsia, and peripartum cardiomyopathy
Authors:
Open Access
- 17 July 2025
- journal article
- Published by Probiologists Limited in Journal of Cellular and Molecular Immunology
- Vol. 4 (1) , 14-18
Abstract
Cardiovascular disease (CVD) is a leading cause of maternal mortality worldwide [1,2]. The molecular mechanisms underlying de novo CVD in pregnancy are not fully understood, which has limited targeted therapeutic development. Our group’s recent articleKeywords
This publication has 36 references indexed in Scilit:
- Two distinct molecular faces of preeclampsia revealed by single-cell transcriptomicsMed, 2023
- Pericytes on placental capillaries in terminal villi preferentially cover endothelial junctions in regions furthest away from the trophoblastPlacenta, 2021
- Oxidative stress: Normal pregnancy versus preeclampsiaBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2020
- Trophoblast type-specific expression of senescence markers in the human placentaPlacenta, 2019
- Telomeres and Cell Senescence - Size Matters NotEBioMedicine, 2017
- The role of cellular senescence in ageing of the placentaPlacenta, 2017
- Differential senescence in feto-maternal tissues during mouse pregnancyPlacenta, 2016
- Telomere homeostasis in trophoblasts and in cord blood cells from pregnancies complicated with preeclampsiaAmerican Journal of Obstetrics and Gynecology, 2016
- Senescence Is a Developmental Mechanism that Contributes to Embryonic Growth and PatterningCell, 2013
- Programmed Cell Senescence during Mammalian Embryonic DevelopmentCell, 2013